These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis. Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276 [TBL] [Abstract][Full Text] [Related]
26. The role of soluble intercellular adhesion molecules in neurodegenerative disorders. Rentzos M; Michalopoulou M; Nikolaou C; Cambouri C; Rombos A; Dimitrakopoulos A; Vassilopoulos D J Neurol Sci; 2005 Feb; 228(2):129-35. PubMed ID: 15694193 [TBL] [Abstract][Full Text] [Related]
27. [Clinical value of soluble adhesion molecules in systemic scleroderma]. Alekperov RT; Timchenko AV; Aleksandrova EN; Samsonov MIu; Guseva NG; Nasonova EL Klin Med (Mosk); 2003; 81(10):43-7. PubMed ID: 14664174 [TBL] [Abstract][Full Text] [Related]
28. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Thomson AW; Satoh S; Nüssler AK; Tamura K; Woo J; Gavaler J; van Thiel DH Clin Exp Immunol; 1994 Jan; 95(1):83-90. PubMed ID: 7904546 [TBL] [Abstract][Full Text] [Related]
29. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192 [TBL] [Abstract][Full Text] [Related]
30. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis. Simpson KJ; Jones AL; Forbes Howie A; Hayes PC Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148 [TBL] [Abstract][Full Text] [Related]
31. Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations. Degiannis D; Seibold JR; Czarnecki M; Raskova J; Raska K Arthritis Rheum; 1990 Mar; 33(3):375-80. PubMed ID: 2317223 [TBL] [Abstract][Full Text] [Related]
32. Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study. Ntelis K; Gkizas V; Filippopoulou A; Davlouros P; Alexopoulos D; Andonopoulos AP; Daoussis D BMC Musculoskelet Disord; 2016 May; 17():213. PubMed ID: 27188755 [TBL] [Abstract][Full Text] [Related]
33. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome. López-Lerma I; Estrach MT J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537 [TBL] [Abstract][Full Text] [Related]
34. Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels. Mittag M; Beckheinrich P; Haustein UF Acta Derm Venereol; 2001; 81(4):294-7. PubMed ID: 11720181 [TBL] [Abstract][Full Text] [Related]
35. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus. Srivastava MD; Rossi TM; Lebenthal E Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726 [TBL] [Abstract][Full Text] [Related]